Business Wire

The newsfeed available here is provided by our content partner Business Wire. This is one of the most important and widest-reaching press services, providing news, press releases and multimedia content to the media, journalists and the public. Business Wire is a subsidiary of the Warren Buffett Group Berkshire Hathaway.
The NewsWire Hub ("X-Billboard") currently comprises four of the most important international news sources and is supplemented by a stock market information service. The individual newswire services complement each other and provide a complementary range of information, more than three quarters of the official news sources on which editors worldwide base their stock market reporting. Your advantage: You will find everything here in one overview. You can navigate to the individual sections using the control elements. In the terminal view, you can carry out individual searches at company level.
presented by
N
More Tools & Gadgets
F&G: 63
5.916,99 S&P · 19,88 Vola-Index · 105.394,51 BTC · 1,13975 EURUSD
System-State: Number of processed items 45.963 Notifications successully processed since Inception
EXCHANGE NEWSBOARD
                              
NEWSWIRE INFOBOARD
                              
Business Wire is an important news source that can be accessed via the X-Billboard. It is part of the Newswire Hub, which bundles important international news sources for stock market participants in one central location. If you want to get a quick overview, you can easily scroll through the headlines. If you want to look at the news in more detail, you can use the detailed views of the info cards to directly access the respective news item and other analysis tools.
NEWS
EXPLORER
US45168D1046
State: 03.06.2025 | 12PM
Do you already know our new terminal view? Click here.
FIGI: BBG000BLRT07
IDXX
IDEXX Laboratories, Inc.
GICS: - · Sector: Healthcare · Sub-Sector: Diagnostics & Research
NAME
IDEXX Laboratories, Inc.
ISIN
US45168D1046
TICKER
IDXX
MIC
XNAS
REUTERS
IDXX.OQ
BLOOMBERG
IDXX US
Tue, 13.05.2025       IDEXX Laboratories
US45168D1046

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Andrew Emerson, Executive Vice President and Chief Financial Officer, and Tina Hunt, Executive Vice President, Global Strategy and Commercial, will participate in a fireside chat at the Stifel Jaws & Paws Conference on Wednesday, May 28,...
Read More
IDEXX Laboratories
Technical Analysis Termsheet Terminal
Permalink
Thu, 01.05.2025       IDEXX Laboratories
US45168D1046

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced first quarter results. “IDEXX drove solid execution in the first quarter while advancing key enablers of our innovation-driven growth strategy. At the end of March, IDEXX launched a first-of-its-kind innovation, IDEXX Cancer Dx™, in our North Am...
Read More
IDEXX Laboratories
Technical Analysis Termsheet Terminal
Permalink
Thu, 03.04.2025       IDEXX Laboratories
US45168D1046

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 first quarter financial results for Thursday, May 1, 2025, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day. Individuals can access a live webcast of the con...
Read More
IDEXX Laboratories
Technical Analysis Termsheet Terminal
Permalink
Thu, 13.02.2025       IDEXX Laboratories
US45168D1046

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in two upcoming conferences: Thursday, February 27, 9:05 am – 9:45 am EST – Mike Erickson, PhD, Executive Vice President, and General Manager, Point of Care Diagnostics and Telemedicine, and Andrew Emerson, Senior Vice President, Corporate an...
Read More
IDEXX Laboratories
Technical Analysis Termsheet Terminal
Permalink
Mon, 03.02.2025       IDEXX Laboratories
US45168D1046

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced fourth quarter and full year results. “IDEXX had a solid finish to 2024, supported by continued high levels of execution by IDEXX teams globally,” said Jay Mazelsky, President and Chief Executive Officer. "The Company is on the front end of a n...
Read More
IDEXX Laboratories
Technical Analysis Termsheet Terminal
Permalink
Thu, 16.01.2025       IDEXX Laboratories
US45168D1046

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 fourth quarter and full year financial results for Monday, February 3, 2025, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day. Individuals can access a live...
Read More
IDEXX Laboratories
Technical Analysis Termsheet Terminal
Permalink
Mon, 09.12.2024       IDEXX Laboratories
US45168D1046

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that the Company’s Board of Directors authorized an increase in its ongoing share repurchase program, authorizing the repurchase of up to five million additional shares of the Company’s common stock. Repurchases may be made at management’s discre...
Read More
IDEXX Laboratories
Technical Analysis Termsheet Terminal
Permalink
Thu, 21.11.2024       IDEXX Laboratories
US45168D1046

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Brian McKeon has decided to retire from IDEXX effective June 1, 2025. Andrew Emerson, currently Senior Vice President, Corporate and Companion Animal Group (“CAG”) Finance, will succeed Mr. McKeon as IDEXX’s Executive Vice President, Chief F...
Read More
IDEXX Laboratories
Technical Analysis Termsheet Terminal
Permalink
Thu, 31.10.2024       IDEXX Laboratories
US45168D1046

In the 2024 Growth and Financial Performance Outlook section, second paragraph, second sentence should read: At midpoint, projected full year comparable operating profit margin expansion of 30 - 60 basis points includes a ~40 basis point negative growth impact from lapping a customer contract resolution payment in the first quarter of 2023. (inste...
Read More
IDEXX Laboratories
Technical Analysis Termsheet Terminal
Permalink
Thu, 31.10.2024       IDEXX Laboratories
US45168D1046

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced third quarter results. Third Quarter Results The Company reports revenues of $976 million for the third quarter of 2024, an increase of 7% as reported and 6% organic, driven by Companion Animal Group ("CAG") growth of 7% as reported and 6% orga...
Read More
IDEXX Laboratories
Technical Analysis Termsheet Terminal
Permalink
Mon, 30.09.2024       IDEXX Laboratories
US45168D1046

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 third quarter results for Thursday, October 31, 2024, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. EDT on that day. Individuals can access a live webcast of the confere...
Read More
IDEXX Laboratories
Technical Analysis Termsheet Terminal
Permalink
Wed, 21.08.2024       IDEXX Laboratories
US45168D1046

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Jay Mazelsky, President and Chief Executive Officer, and Brian McKeon, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, Sep...
Read More
IDEXX Laboratories
Technical Analysis Termsheet Terminal
Permalink

The information provided here is not subject to any editorial processing. It is prepared fully automatically and enriched with additional information and further research options. The aim of the content is to provide information seekers with the relevant information quickly and easily. A link back to the information provider and owner ensures that the data prepared here can be compared with the source information if required. The newsboard does not show information in real time. Please contact the exchange operator for this information if required. There is no claim to completeness. High availability cannot be guaranteed. If you notice any errors in the functionality, please let us know using the "Report a Bug" form below.

RAW DATA PROCESSING means that raw data is processed without changing the content. The data is supplemented to improve the interpretation of the information in terms of usability.

Note: The newswire crosslink panel in the upper area allows you to quickly and conveniently access additional sources of information. In the terminal view, the news is filtered at company level and enables targeted research.

On behalf of the trading community, we would like to thank the operators of the trading venues for providing information services.